Astellas Buys Iveric Bio for $5.9 Billion to Bolster Ophthalmology Portfolio By Mark TerryMay 2, 2023 Tokyo-based Astellas Pharma is buying Parsippany, NJ’s Iveric Bio for $5.9 billion. Iveric Bio [….]
Astellas Buys Iveric Bio for $5.9 Billion to Bolster Ophthalmology Portfolio
![](https://biobuzz.io/wp-content/uploads/2023/05/Untitled-design-2-300x300.png)